The molecular logic of endocannabinoid signalling

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633

Molecular characterization of a peripheral receptor for cannabinoids

Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993) · Nature · doi:10.1038/365061a0 · Cited by 5,092

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011

Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB 1 Receptor Knockout Mice

Ledent, C. A., Valverde, O., Cossu, G., Petitet, F., Aubert, J.-F., Beslot, F., Böhme, G. A., Impérato, A., Pedrazzini, T., Roques, B. P., et al. (1999) · Science · doi:10.1126/science.283.5400.401 · Cited by 3,628

Drug Addiction, Dysregulation of Reward, and Allostasis

Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913

Determination and characterization of a cannabinoid receptor in rat brain

Devane, W. A., Dysarz, F. A., Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09876-1 · Cited by 2,443 · cited 1×

Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish

Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389

Cannabinoid receptor localization in brain.

Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321

2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain

Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., & Waku, K. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2437 · Cited by 2,196

The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases

Argenziano, M., Tortora, C., Bellini, G., Paola, A. D., Punzo, F., & Rossi, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235875 · Cited by 43

Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders

Navarro, D., Gasparyan, A., Navarrete, F., Torregrosa, A. B., Rubio, G., Marín, M., Acosta, G. B., García‐Gutiérrez, M. S., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094764 · Cited by 47

Expression and distribution of CB1 cannabinoid receptors in the central nervous system of the African cichlid fishPelvicachromis pulcher

Cottone, E., Forno, S., Campantico, E., Guastalla, A., Viltono, L., Mackie, K., & Franzoni, M. F. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20502 · Cited by 43

Effects of the endogenous PPAR‐α agonist, oleoylethanolamide on MDMA‐induced cognitive deficits in mice

Plaza‐Zabala, A., Berrendero, F., Suárez, J., Bermúdez‐Silva, F. J., Fernández‐Espejo, E., Serrano, A., Pavón, F. J., Parsons, L. H., de Fonseca, F. R., Maldonado, R. J., et al. (2009) · Synapse · doi:10.1002/syn.20733 · Cited by 43

Cannabinoid Receptor-Mediated Regulation of Neuronal Activity and Signaling in Glomeruli of the Main Olfactory Bulb

Wang, Z., Sun, L., & Heinbockel, T. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.5333-11.2012 · Cited by 42

Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties

Pember, S. O., Mejia, G. L., Price, T. J., & Pasteris, R. J. (2016) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2016.02.061 · Cited by 43

Targeting the endocannabinoid system with microbial interventions to improve gut integrity

Jansma, J., Brinkman, F. N., van Hemert, S., & Aidy, S. E. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110169 · Cited by 45

Anandamide and NADA bi‐directionally modulate presynaptic Ca2+ levels and transmitter release in the hippocampus

Köfalvi, A., Pereira, M. F., Rebola, N., Rodrigues, R. J., Oliveira, C. R., & Cunha, R. A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707252 · Cited by 42

Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine

Machado, F. C., Zambelli, V. O., Fernandes, A. C., Heimann, A. S., Cury, Y., & Picolo, G. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12488 · Cited by 42

The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: A role in uterine remodelling

Fonseca, B. M., Correia‐da‐Silva, G., Taylor, A. H., Lam, P. M. W., Marczylo, T. H., Bell, S. C., Konje, J. C., & Teixeira, N. A. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.08.006 · Cited by 42

N-arachidonoyl-serotonin, a dual FAAH and TRPV1 blocker, inhibits the retrieval of contextual fear memory: Role of the cannabinoid CB1 receptor in the dorsal hippocampus

Gobira, P. H., Lima, I. V. D. A., Batista, L. A., de Oliveira, A. C., Resstel, L. B. M., Wotjak, C. T., de Aguiar, D. C., & Moreira, F. A. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117691567 · Cited by 45

Tandem mass spectrometric data–FAAH inhibitory activity relationships of some carbamic acid O‐aryl esters

Basso, E., Duranti, A., Mor, M., Piomelli, D., Tontini, A., Tarzia, G., & Traldi, P. (2004) · Journal of Mass Spectrometry · doi:10.1002/jms.729 · Cited by 42

Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation

Bashashati, M., Nasser, Y., Keenan, C. M., Ho, W., Piscitelli, F., Nalli, M., Mackie, K., Storr, M., Marzo, V. D., & Sharkey, K. A. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13114 · Cited by 41

Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum

Musella, A., Chiara, V. D., Rossi, S., Cavasinni, F., Castelli, M., Cantarella, C., Mataluni, G., Bernardi, G., & Centonze, D. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.02.058 · Cited by 41

N-Acylethanolamine Levels and Expression of Their Metabolizing Enzymes during Pregnancy

Fonseca, B. M., Correia‐da‐Silva, G., Taylor, A. H., Lam, P. M. W., Marczylo, T. H., Konje, J. C., Bell, S. C., & Teixeira, N. A. A. (2010) · Endocrinology · doi:10.1210/en.2009-1424 · Cited by 43

The interplay between inflammatory cytokines and the endocannabinoid system in the regulation of synaptic transmission

Rossi, S., Motta, C., Musella, A., & Centonze, D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.09.022 · Cited by 42

Computational insights into function and inhibition of fatty acid amide hydrolase

Palermo, G., Röthlisberger, U., Cavalli, A., & Vivo, M. D. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.09.037 · Cited by 41

GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors

Gasperi, V., Dainese, E., Oddi, S., Sabatucci, A., & Maccarrone, M. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130108 · Cited by 41

Endocannabinoids and striatal function

Moreira, F. A., Jupp, B., Belin, D., & Dalley, J. W. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000109 · Cited by 44

Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders

Suryadevara, U., Bruijnzeel, D. M., Nuthi, M., Jagnarine, D. A., Tandon, R., & Bruijnzeel, A. W. (2017) · Current Neuropharmacology · doi:10.2174/1570159x14666161101095325 · Cited by 43

Neuroprotective Effects of MAGL (Monoacylglycerol Lipase) Inhibitors in Experimental Ischemic Stroke

Choi, S., Arai, A. L., Mou, Y., Kang, B., Yen, C. C., Hallenbeck, J. M., & Silva, A. C. (2018) · Stroke · doi:10.1161/strokeaha.117.019664 · Cited by 41

New Perspectives on the Use of Cannabis in the Treatment of Psychiatric Disorders

Scherma, M., Masia, P., Deidda, M. L., Fratta, W., Tanda, G., & Fadda, P. (2018) · Medicines · doi:10.3390/medicines5040107 · Cited by 43

A proposed modulatory role of the endocannabinoid system on adipose tissue metabolism and appetite in periparturient dairy cows

Myers, M. N., Zachut, M., Tam, J., & Contreras, G. A. (2021) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00549-3 · Cited by 43

The Endocannabinoid System: A New Molecular Target for the Treatment of Tobacco Addiction

Scherma, M., Fadda, P., Foll, B. L., Forget, B., Fratta, W., Goldberg, S. R., & Tanda, G. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708786927859 · Cited by 43

Comparison of Cannabinoid CB1Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470

Verdurand, M., Nguyen, V., Stark, D., Zahra, D., Grégoire, M., Greguric, I. D., & Zavitsanou, K. (2011) · International Journal of Molecular Imaging · doi:10.1155/2011/548123 · Cited by 41

Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia

Fuxé, K., Marcellino, D. J., Woods, A. S., Leo, G., Antonelli, T., Ferraro, L., Tanganelli, S., & Agnati, L. F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-008-0174-9 · Cited by 40

Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions

Rivera, P., Romero‐Zerbo, S., Pavón, F. J., Serrano, A., López-Ávalos, M. D., Cifuentes, M., Grondona, J. M., Bermúdez‐Silva, F. J., Fernández‐Llebrez, P., de Fonseca, F. R., et al. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07650.x · Cited by 44

Role of lipid-derived mediators in skeletal muscle insulin resistance

Taube, A., Eckardt, K., & Eckel, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00241.2009 · Cited by 40

Endocannabinoid signaling in microglia

Marinelli, S., Marrone, M. C., Domenico, M. D., & Marinelli, S. (2022) · Glia · doi:10.1002/glia.24281 · Cited by 42

Endogenous lipid activated G protein-coupled receptors: Emerging structural features from crystallography and molecular dynamics simulations

Hurst, D. P., Schmeisser, M. G., & Reggio, P. H. (2013) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2013.01.009 · Cited by 42

BDNF Interacts with Endocannabinoids to Regulate Cocaine-Induced Synaptic Plasticity in Mouse Midbrain Dopamine Neurons

Zhong, P., Liu, Y. U., Hu, Y., Wang, T., Zhao, Y.-P., & Liu, Q.-S. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2924-14.2015 · Cited by 41

Endocannabinoids and Schizophrenia

Desfossés, J., Stip, É., Bentaleb, L. A., & Potvin, S. (2010) · Pharmaceuticals · doi:10.3390/ph3103101 · Cited by 42

Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system

Rawas, R. E., Thiriet, N., Nader, J., Lardeux, V., Jaber, M., & Solinas, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.03.025 · Cited by 40

Endocannabinoid signaling in the spinal locomotor circuitry

Manira, A. E., Kyriakatos, A., Nanou, E., & Mahmood, R. Z. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.06.020 · Cited by 40

The role of the endocannabinoid system in the regulation of energy homeostasis

Cota, D., & Woods, S. C. (2005) · Current Opinion in Endocrinology & Diabetes · doi:10.1097/01.med.0000178715.87999.69 · Cited by 41

Effects on Cell Viability

Guzmán, M. (2005) · Springer eBooks · doi:10.1007/3-540-26573-2_21 · Cited by 40

The Endocannabinoid System: A Putative Role in Neurodegenerative Diseases

Iorio, G. D., Lupi, M., Sarchione, F., Matarazzo, I., Santacroce, R., Petruccelli, F., Martinotti, G., & Giannantonio, M. D. (2013) · international journal high risk behaviors & addiction · doi:10.5812/ijhrba.9222 · Cited by 39

Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity

Mouro, F. M., Ribeiro, J. A., Sebastião, A. M., & Dawson, N. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14549 · Cited by 41

Endocannabinoid long-term depression revealed at medial perforant path excitatory synapses in the dentate gyrus

Peñasco, S., Rico‐Barrio, I., Puente, N., Gómez‐Urquijo, S., Fontaine, C. J., Huguet, J. E., Achicallende, S., Ramos, A., Reguero, L., Elezgarai, I., et al. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.020 · Cited by 39

Age-dependent Alteration in Mitochondrial Dynamics and Autophagy in Hippocampal Neuron of Cannabinoid CB1 Receptor-deficient Mice

Kataoka, K., Bilkei‐Gorzó, A., Nozaki, C., Togo, A., Nakamura, K., Ohta, K., Zimmer, A., & Asahi, T. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2020.03.014 · Cited by 37

Mechanisms for the Risk of Acute Coronary Syndrome and Arrhythmia Associated With Phytogenic and Synthetic Cannabinoid Use

Richards, J. R. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420935743 · Cited by 39

Cannabidiol and the Canonical WNT/β-Catenin Pathway in Glaucoma

Vallée, A., Lecarpentier, Y., & Vallée, J.-N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073798 · Cited by 40

The role of endocannabinoid pathway in the neuropathology of Alzheimer’s disease: Can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer’s disease?

Bajaj, S., Jain, S., Vyas, P., Bawa, S., & Vohora, D. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.022 · Cited by 41

Time dependent alterations on tyrosine hydroxylase, opioid and cannabinoid CB1 receptor gene expressions after acute ethanol administration in the rat brain

Oliva, J. M., Ortiz, S., Pérez-Rial, S., & Manzanares, J. (2007) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2007.09.001 · Cited by 41

Hyperactivity induced by the dopamine D2/D3 receptor agonist quinpirole is attenuated by inhibitors of endocannabinoid degradation in mice

Rojas, M. J. L., Galeano, P., Suárez, J., Araos, P. F., Santín, L. J., de Fonseca, F. R., & Blanco, E. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000569 · Cited by 38

Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse

Skike, C. E. V., Maggio, S. E., Reynolds, A. R., Casey, E. M., Bardo, M. T., Dwoskin, L. P., Prendergast, M., & Nixon, K. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.004 · Cited by 43

Frequent Low-Dose Δ9-Tetrahydrocannabinol in Adolescence Disrupts Microglia Homeostasis and Disables Responses to Microbial Infection and Social Stress in Young Adulthood

Lee, H.-L., Jung, K.-M., Fotio, Y., Squire, E., Palese, F., Lin, L., Torrens, A., Ahmed, F., Mabou Tagne, A., Ramirez, J., et al. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.04.017 · Cited by 38

Distribution of diacylglycerol lipase alpha, an endocannabinoid synthesizing enzyme, in the rat forebrain

Suárez, J., Ortiz, Ó., Puente, N., Bermúdez‐Silva, F. J., Blanco, E., Fernández‐Llebrez, P., Grandes, P., de Fonseca, F. R., & Moratalla, R. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.062 · Cited by 38

Role of Endocannabinoid System in the Ventral Hippocampus of Rats in the Modulation of Anxiety‐Like Behaviours

Roohbakhsh, A., Keshavarz, S., Hasanein, P., Rezvani, M. E., & Moghaddam, A. H. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00449.x · Cited by 39

Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain

Bouchard, J., Casanova, C., Cécyre, B., & Redmond, W. J. (2015) · Neural Plasticity · doi:10.1155/2016/9247057 · Cited by 41

Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs

Batista, L. A., Gobira, P. H., Viana, T. G., de Aguiar, D. C., & Moreira, F. A. (2014) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000073 · Cited by 38

The motivation for exercise over palatable food is dictated by cannabinoid type-1 receptors

Muguruza, C., Redon, B., Fois, G. R., Hurel, I., Scocard, A., Nguyen, C., Stevens, C. G., Gómez, E. S., Varilh, M., Cannich, A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126190 · Cited by 41

Biological bases for a possible effect of cannabidiol in Parkinson’s disease

Ferreira‐Junior, N. C., Campos, A. C., Guimarães, F. S., Bel, E. A. D., Zimmermann, P. M. D. R., Brum, L., Hallak, J. E. C., Crippa, J. A. S., & Zuardi, A. W. (2019) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2019-0460 · Cited by 44

Chronic cocaine sensitizes striatal GABAergic synapses to the stimulation of cannabinoid CB1 receptors

Centonze, D., Rossi, S., Chiara, V. D., Prosperetti, C., Battista, N., Bernardi, G., Mercuri, N. B., Usiello, A., & Maccarrone, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05433.x · Cited by 38

Blocking the postpartum mouse dam's CB1 receptors impairs maternal behavior as well as offspring development and their adult social–emotional behavior

Schechter, M., Pinhasov, A., Weller, A., & Fride, E. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.10.016 · Cited by 40

The hypophysial pars tuberalis transduces photoperiodic signals via multiple pathways and messenger molecules

Yasuo, S., & Korf, H. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2010.11.006 · Cited by 38

The endogenous cannabinoid system and the treatment of marijuana dependence

Piomelli, D. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.018 · Cited by 38

Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives

Bononi, G., Stefano, M. D., Poli, G., Ortore, G., Meier, P., Masetto, F., Caligiuri, I., Rizzolio, F., Macchia, M., Chicca, A., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01806 · Cited by 42

The endocannabinoid 2-arachidonoylglycerol mediates D1 and D2 receptor cooperative enhancement of rat nucleus accumbens core neuron firing

Seif, T., Makriyannis, A., Kunos, G., Bonci, A., & Hopf, F. W. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.07.055 · Cited by 37

β-Lactones Inhibit N-acylethanolamine Acid Amidase by S-Acylation of the Catalytic N-Terminal Cysteine

Armirotti, A., Romeo, E., Ponzano, S., Mengatto, L., Dionisi, M., Karacsonyi, C., Bertozzi, F., Garau, G., Tarozzo, G., Reggiani, A. M., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300056y · Cited by 37

Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems

Zarrindast, M., Mahboobi, S., Sadat‐Shirazi, M., & Ahmadi, S. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881110376688 · Cited by 37

The role of fatty acid amide hydrolase inhibition in nicotine reward and dependence

Muldoon, P. P., Lichtman, A. H., Parsons, L. H., & Damaj, M. I. (2012) · Life Sciences · doi:10.1016/j.lfs.2012.05.015 · Cited by 39

Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake

Gómez, E. S., Massa, F., Bellocchio, L., Rueda‐Orozco, P. E., Ciofi, P., Cota, D., Oliet, S. H. R., Prospero-Garcia, O. E., & Marsicano, G. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.01.005 · Cited by 37

Peripheral analgesia: Hitting pain where it hurts

McDougall, J. J. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.011 · Cited by 38

Cannabinoids and Vanilloids in Schizophrenia: Neurophysiological Evidence and Directions for Basic Research

Ruggiero, R. N., Rossignoli, M. T., Ross, J. B. D., Hallak, J. E. C., Leite, J. P., & Bueno-Júnior, L. S. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00399 · Cited by 39

Novel Optogenetic Approaches in Epilepsy Research

Cela, E., & Sjöström, P. J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00947 · Cited by 38

Intermittent ethanol exposure during adolescence impairs cannabinoid type 1 receptor-dependent long-term depression and recognition memory in adult mice

Peñasco, S., Rico-Barrio, I., Puente, N., Fontaine, C. J., Ramos, A., Reguero, L., Gerrikagoitia, I., de Fonseca, F. R., Suarez, J., Barrondo, S., et al. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0530-5 · Cited by 37

A Glial-Neuronal Circuit in the Median Eminence Regulates Thyrotropin-Releasing Hormone-Release via the Endocannabinoid System

Farkas, E., Varga, E., Kovács, B., Szilvásy‐Szabó, A., Cote-Vélez, A., Péterfi, Z., Matziari, M., Tóth, M., Zelena, D., Mezriczky, Z., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100921 · Cited by 37

Integration of Endocannabinoid Signaling into the Neural Network Regulating Stress-Induced Activation of the Hypothalamic–Pituitary–Adrenal Axis

Gorzalka, B. B., & Hill, M. N. (2009) · Current topics in behavioral neurosciences · doi:10.1007/978-3-540-88955-7_12 · Cited by 38

An Overview on the Biochemistry of the Cannabinoid System

Gómez‐Ruíz, M., Hernández, M., de Miguel, R., & Ramos, J. A. (2007) · Molecular Neurobiology · doi:10.1007/s12035-007-0015-0 · Cited by 38

The endocannabinoid system: A new entry in remote cell death mechanisms

Viscomi, M. T., Oddi, S., Latini, L., Bisicchia, E., Maccarrone, M., & Molinari, M. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.03.023 · Cited by 37

Diacylglycerol Lipase-α and -β Control Neurite Outgrowth in Neuro-2a Cells through Distinct Molecular Mechanisms

Jung, K., Astarita, G., Thongkham, D., & Piomelli, D. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070458 · Cited by 37

A synaptocentric view of the neuroendocrine response to stress

Cusulin, J. I. W., & Bains, J. S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07513.x · Cited by 40

Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes

Lu, D., Dopart, R., & Kendall, D. A. (2015) · Cell Stress and Chaperones · doi:10.1007/s12192-015-0653-5 · Cited by 36

Distinct roles of group I mGlu receptors in striatal function

Bonsi, P., Platania, P., Martella, G., Madeo, G., Vita, D., Tassone, A., Bernardi, G., & Pisani, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.05.020 · Cited by 36

Anandamide Hydrolysis in FAAH Reveals a Dual Strategy for Efficient Enzyme-Assisted Amide Bond Cleavage via Nitrogen Inversion

Palermo, G., Campomanes, P., Cavalli, A., Röthlisberger, U., & Vivo, M. D. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp5052276 · Cited by 36

Discovery of MK-3168: A PET Tracer for Imaging Brain Fatty Acid Amide Hydrolase

Liu, P., Hamill, T. G., Chioda, M. D., Chobanian, H. R., Fung, S., Guo, Y., Chang, L. L., Bakshi, R. K., Hong, Q., Dellureficio, J., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000996 · Cited by 36

Lipid Profiling Reveals Tissue‐Specific Differences for Ethanolamide Lipids in Mice Lacking Fatty Acid Amide Hydrolase

Kilaru, A., Isaac, G., Tamura, P. J., Baxter, D., Duncan, S. R., Venables, B. J., Welti, R., Koulen, P., & Chapman, K. D. (2010) · Lipids · doi:10.1007/s11745-010-3457-5 · Cited by 36

Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism

Alén, F., Crespo, I., Ramírez-López, M. T., Jagerovic, N., Goya, P., de Fonseca, F. R., de Heras, R. G., & Orío, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060918 · Cited by 36

Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome

Juan, C., Chen, K.-H., Wang, P., Hwang, J., & Seow, K. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.03.027 · Cited by 36

Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model

Miller, S., Leishman, E., Hu, S. S., Elghouche, A. N., Daily, L., Murataeva, N., Bradshaw, H. B., & Straiker, A. J. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-19356 · Cited by 36

Role of endocannabinoid system in dopamine signalling within the reward circuits affected by chronic pain

Mlost, J., Wąsik, A., & Starowicz, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.029 · Cited by 38

Healing autism spectrum disorder with cannabinoids: a neuroinflammatory story

Carbone, E., Manduca, A., Cacchione, C., Vicari, S., & Trezza, V. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.12.009 · Cited by 38

Endocannabinoids and cortical plasticity: CB1R as a possible regulator of the excitation/inhibition balance in health and disease

Durieux, L. J. A., Gilissen, S. R. J., & Arckens, L. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15110 · Cited by 40

Synaptic changes induced by cannabinoid drugs and cannabis use disorder

Augustin, S. M., & Lovinger, D. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105670 · Cited by 38

Endocannabinoid signaling in synaptic function

Noriega‐Prieto, J. A., Kofuji, P., & Araque, A. (2022) · Glia · doi:10.1002/glia.24256 · Cited by 36

Cannabis sativaand the Endogenous Cannabinoid System: Therapeutic Potential for Appetite Regulation

Farrimond, J. A., Mercier, M. S., Whalley, B. J., & Williams, C. M. (2011) · Phytotherapy Research · doi:10.1002/ptr.3375 · Cited by 37

Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain

Cenni, G., Blandina, P., Mackie, K., Nosi, D., Formigli, L., Giannoni, P., Ballini, C., Corte, L., Mannaioni, P. F., & Passani, M. B. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05046.x · Cited by 36

Δ9-tetrahydrocannabinol increases C6 glioma cell death produced by oxidative stress

Goncharov, I., Weiner, L. M., & Vogel, Z. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.04.042 · Cited by 36

A CB1/CB2 receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin

Arévalo‐Martín, Á., Molina‐Holgado, E., & Guaza, C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.04.012 · Cited by 36

Insights into the mechanism and inhibition of fatty acid amide hydrolase from quantum mechanics/molecular mechanics (QM/MM) modelling

Lodola, A., Mor, M., Sirirak, J., & Mulholland, A. J. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370363 · Cited by 36

Quantum Mechanics/Molecular Mechanics Modeling of Fatty Acid Amide Hydrolase Reactivation Distinguishes Substrate from Irreversible Covalent Inhibitors

Lodola, A., Capoferri, L., Rivara, S., Tarzia, G., Piomelli, D., Mulholland, A. J., & Mor, M. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301867x · Cited by 36

Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies

Sharkey, K. A., & Pittman, Q. J. (2005) · Science s STKE · doi:10.1126/stke.2772005pe15 · Cited by 36

Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas

Marco, E. M., Rubino, T., Adriani, W., Viveros, M., Parolaro, D., & Laviola, G. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.037 · Cited by 35

Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats

Schreiber, A. K., Neufeld, M., Jesus, C. H. A., & da Cunha, J. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.009 · Cited by 35

Therapeutical Potential of CB2 Receptors in Immune-Related Diseases

Leleu‐Chavain, N., Desreumaux, P., Chavatte, P., & Millet, R. (2014) · Current Molecular Pharmacology · doi:10.2174/1874467207666140219122337 · Cited by 37

The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence

Scherma, M., Fattore, L., Castelli, M. P., Fratta, W., & Fadda, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990429 · Cited by 36

Preclinical studies on the reinforcing effects of cannabinoids. A tribute to the scientific research of Dr. Steve Goldberg

Tanda, G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4244-7 · Cited by 37

Effects of JWH015 in cytokine secretion in primary human keratinocytes and fibroblasts and its suitability for topical/transdermal delivery

Bort, A., Alvarado-Vazquez, P. A., Moracho-Vilrriales, C., Virga, K. G., Gumina, G., Romero-Sandoval, A. E., & Asbill, S. (2017) · Molecular Pain · doi:10.1177/1744806916688220 · Cited by 35

Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture

Yang, C., Liu, J., Wang, J., Yin, A., Jiang, Z., Ye, S., Liu, X., Zhang, X., Wang, L., & Xiong, L. (2021) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x21994395 · Cited by 34

Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity

Basavarajappa, B. S. (2007) · Current Neuropharmacology · doi:10.2174/157015907780866910 · Cited by 115

The Endocannabinoid System

Basavarajappa, B. S., Yalamanchili, R., Cooper, T. B., & Hungund, B. L. (2008) · Springer eBooks · doi:10.1007/978-0-387-30382-6_14 · Cited by 7

Functional diversity on synaptic plasticity mediated by endocannabinoids

Cachope, R. (2012) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2011.0386 · Cited by 37

Endocannabinoids and Synaptic Function in the CNS

Hashimotodani, Y., Ohno‐Shosaku, T., & Kano, M. (2007) · The Neuroscientist · doi:10.1177/1073858406296716 · Cited by 210

Synaptic effects of cannabinoids

Benarroch, E. E. (2014) · Neurology · doi:10.1212/wnl.0000000000001013 · Cited by 25